Skip to content

Clinical trials

Central Nervous System Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Diseases Country / region: Germany Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20092
20103
20114
20121
20144
20151
20162
20172
20183
20193
20204
20211
20223
20233
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Terminated8
Recruiting4
Active, not recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
AstraZeneca3
Auspex Pharmaceuticals, Inc.2
Leipzig University Medical Center2
Novartis Pharmaceuticals2
Alkahest, Inc.1
Avraham Pharmaceuticals Ltd1
Bayer1
Bial R&D Investments, S.A.1
Biogen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Diseases40
Brain Diseases29
Nervous System Diseases26
Neurodegenerative Diseases16
Movement Disorders11
Dementia10
Mental Disorders10
Parkinson Disease9
Alzheimer Disease8
Parkinsonian Disorders8

Trials

Showing 76 to 40 of 40. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.